Delivery Order SPE2DE24D0021-SPE2D625F0DYS
- Not listed
- Fisher Scientific Company L.L.C. was awarded a $1,098 fixed-price delivery order titled "TAQMAN Fast Advance MMIX" by the Medical Supply Chain, a defense-oriented federal agency, on August 15, 2025. The contract represents a child award under a larger vehicle and carries no set-aside designation, indicating open competition. Performance will be completed by August 27, 2025, at Fisher Scientific's facility in Pittsburgh, PA 15275. The pricing structure includes economic price adjustment...
- Fisher Scientific Company L.L.C. was awarded a delivery order valued at $1,312.00 on April 27, 2025, for TaqMan Fast Universal supplies under a fixed-price contract with economic price adjustment provisions. The award, which carries no set-aside designation, supports the Defense Department's Medical Supply Chain operations with performance based in Pittsburgh, Pennsylvania, and an ultimate completion date of May 7, 2025. As a child contract under a larger vehicle, this delivery order leverages...
- Fisher Scientific Company L.L.C. received a delivery order contract award from the Medical Supply Chain, a defense-focused federal agency, on August 6, 2025, for the procurement of FG TaqMan Fast PCR UMM reagent in 50-milliliter quantities. The contract is valued at $6,089.00 under a fixed-price structure with economic price adjustment provisions and carries an ultimate completion date of August 18, 2025. The award utilized open competition with no set-aside designation, and the place of...
- The U.S. Defense Department's Medical Supply Chain division awarded a $2,272.54 fixed-price delivery order with economic price adjustment to Fisher Scientific Company L.L.C. on August 11, 2025. Designated as contract number 4569047387 and titled "TAQMAN FAST ADVANCE MMIX," this child delivery order is scheduled for completion by August 21, 2025, with performance conducted in Pittsburgh, Pennsylvania. Fisher Scientific, a major federal supplier of laboratory supplies, scientific...
- Fisher Scientific Company L.L.C. was awarded a delivery order valued at $3,487.68 under contract number 4569355487, titled "TAQMAN FAST ADVANCED MMIX," with an ultimate completion date of September 18, 2025. The contract employs fixed-price pricing with economic price adjustment and will be performed in Pittsburgh, Pennsylvania. This delivery order, issued without a set-aside designation, represents a child contract under a larger federal procurement vehicle. The funding agency is...
- Fisher Scientific Company L.L.C. was awarded a delivery order on August 7, 2025, for TaqMan Fast Virus 1-Step MMix, a molecular diagnostic reagent used in viral testing applications. This fixed-price contract with economic price adjustment has a ceiling value of $4,165.58 and is scheduled for completion by August 19, 2025. The work will be performed in Pittsburgh, Pennsylvania. This delivery order represents a child contract, indicating it was issued under an existing contract vehicle, likely...
- The U.S. Department of Defense's Medical Supply Chain awarded a delivery order valued at $4,011.83 to Fisher Scientific Company L.L.C. for TAQMAN FAST VIRUS 1-STEP MMIX, a specialized molecular diagnostic reagent used in rapid viral detection and analysis. This fixed-price delivery order with economic price adjustment was issued on August 13, 2025, with an ultimate completion date of August 25, 2025, and is being fulfilled at Fisher Scientific's Pittsburgh, Pennsylvania location. The award...
- The U.S. Department of Defense's Medical Supply Chain awarded a delivery order valued at $1,259.00 to Fisher Scientific Company L.L.C. on September 8, 2025, for TaqMan Advanced microRNA cDNA synthesis products. This fixed-price contract with economic price adjustment will be performed in Pittsburgh, PA, with a completion date of September 15, 2025. The award was made through open competition with no set-aside designation, reflecting Fisher Scientific's demonstrated competitive capability in...
- Fisher Scientific Company L.L.C. was awarded a delivery order valued at $1,782.05 for FG TaqMan Fast Universal PCR supplies on July 29, 2025, with an ultimate completion date of August 8, 2025. This fixed-price contract with economic price adjustment was awarded without a set-aside designation by the Medical Supply Chain division of the Defense Department. The work will be performed in Pittsburgh, Pennsylvania. As a child contract under a larger vehicle, this delivery order represents a discrete...
- Fisher Scientific Company L.L.C. was awarded a delivery order valued at $1,173.24 on August 6, 2025, for the supply of MAGMAX viral/pathogen products to support the Medical Supply Chain, a defense-related federal agency. This fixed-price delivery order with economic price adjustment features will be performed in Pittsburgh, Pennsylvania, with an ultimate completion date of August 27, 2025. The award was made through open competition with no set-aside designation, demonstrating Fisher...
- SPE2DE24D0021Indefinite Delivery Contract
- SPE2DE24D0021-SPE2D625F0DYSDelivery Order
Fisher Scientific Company L.L.C. received a delivery order award valued at $7,617.43 from the Defense Medical Supply Chain on August 5, 2025, for the procurement of TAQMAN UNIV MMIX 10X5ML products. This fixed-price contract with economic price adjustment provisions has an ultimate completion date of August 15, 2025, and will be performed in Pittsburgh, Pennsylvania. The award was made through open competition with no set-aside designation, reflecting Fisher Scientific's established competitive capabilities as a major supplier of laboratory and scientific equipment to federal agencies. As a child contract associated with a larger vehicle, this delivery order represents a continuation of Fisher Scientific's extensive support to defense and civilian agencies for specialized laboratory supplies and medical equipment. The company, registered in SAM.gov since 2001, has demonstrated broad expertise across multiple scientific domains and maintains significant relationships with agencies including the National Institutes of Health, Department of Veterans Affairs, and the Department of Defense. The relatively short performance period and product specification suggest this procurement addresses an immediate operational need for molecular biology reagents within the federal medical supply chain infrastructure.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $7.6k | 8/5/25 |